Drug Design Studio (DDS) 2.0: A Unified Platform for Network Pharmacology Integrated with Docking and Virtual Screening Workflow for Covalent/Non-Covalent Binders

Mahmoud E. Soliman

Open source

DOI
10.3390/ijms27177874
Published
2026-09-03
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27177874,
  title = {Drug Design Studio (DDS) 2.0: A Unified Platform for Network Pharmacology Integrated with Docking and Virtual Screening Workflow for Covalent/Non-Covalent Binders},
  author = {Mahmoud E. Soliman},
  year = {2026},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms27177874},
  url = {https://doi.org/10.3390/ijms27177874}
}

RIS

TY  - JOUR
TI  - Drug Design Studio (DDS) 2.0: A Unified Platform for Network Pharmacology Integrated with Docking and Virtual Screening Workflow for Covalent/Non-Covalent Binders
AU  - Mahmoud E. Soliman
PY  - 2026
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27177874
UR  - https://doi.org/10.3390/ijms27177874
ER  - 

APA

Soliman, M. E. (2026). Drug Design Studio (DDS) 2.0: A Unified Platform for Network Pharmacology Integrated with Docking and Virtual Screening Workflow for Covalent/Non-Covalent Binders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177874

Source records